However, TMPRSS2-ERG transgenic mice do develop aggressive prostate tumors at advanced age (>2 years), highlighting a context-dependent action of TMPRSS2-ERG in PCa pathogenesis25,28–31. This evidence concerns the gene TMPRSS2 and prostate neoplasm.